Real-time enrollment status for this metastatic cancer clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 12:24 AM UTC
| NCT Number | NCT02710253 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Metastatic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 230 participants |
| Active Locations | 5 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | May 15, 2026 (2 weeks ago) |
As of June 2, 2026: Clinical trial NCT02710253 is currently active_not_recruiting participants. This clinical trial study for metastatic cancer is not currently accepting new participants at 5 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT02710253 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02710253 was last updated 2 weeks ago (May 15, 2026). HelloStudys verifies this status automatically.